Drug profile · INN
levopropoxyphene napsylate anhydrous
NOVRAD
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
levopropoxyphene napsylate anhydrous (NOVRAD) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN levopropoxyphene napsylate anhydrous
Brand NOVRAD
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is levopropoxyphene napsylate anhydrous?
levopropoxyphene napsylate anhydrous (NOVRAD) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for levopropoxyphene napsylate anhydrous?
NOVRAD is a marketed brand name for levopropoxyphene napsylate anhydrous. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levopropoxyphene napsylate anhydrous?
levopropoxyphene napsylate anhydrous has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.